The global healthtech ecosystem has entered a period of profound structural bifurcation, evolving away from the uniform cyclicality that defined previous decades toward a "K-shaped" trajectory. This dynamic represents a market reality where a distinct upper arm, composed of high-growth, clinically validated and AI-native "Health Tech 2.0" companies, achieves record valuations and operational scale, while a lower arm of legacy point solutions, high-burn startups, and undiffer

The transition of women’s health from a fragmented venture capital category into a centralised pillar of global healthcare acquisition strategies marks a definitive shift in the life sciences landscape. In early 2026, the sector has moved beyond the proof-of-concept phase that characterized the early 2020s, entering a period of aggressive consolidation where established healthcare conglomerates, private equity firms, and digital diagnostic leaders are acquiring specialized pl

In an investment banking landscape often dominated by career financiers and generalist institutions, Nelson Advisors has cultivated a distinct identity rooted in the operational experience of its leadership. The firm’s "Founders for Founders" philosophy is not merely a marketing tagline but a fundamental operational differentiator that dictates its approach to client selection, deal structuring and negotiation strategy.